Introduction
BAM15 (N^5,N^6-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine) is a novel mitochondrial protonophore uncoupler that has emerged as a promising therapeutic agent. Unlike traditional uncouplers, BAM15 offers a more targeted approach with reduced side effects, making it a subject of extensive research.
⸻
Chemical Structure and Properties
• Molecular Formula: C₁₆H₁₀F₂N₆O
• CAS Number: 210302-17-3
• Solubility: Low aqueous solubility, which aids in its ability to penetrate cell membranes and mitochondria.
⸻
Mechanism of Action
BAM15 functions by uncoupling oxidative phosphorylation in mitochondria. This process involves:
• Protonophore Activity: BAM15 facilitates the transport of protons across the mitochondrial membrane, disrupting the proton gradient.
• Increased Oxygen Consumption: This disruption leads to an increase in oxygen consumption without a corresponding increase in ATP production, resulting in the dissipation of energy as heat.
• Activation of AMPK: The energy imbalance activates AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis.
⸻
Therapeutic Potential
1. Obesity and Metabolic Disorders
• Weight Management: Studies in mice have shown that BAM15 can prevent and reverse diet-induced obesity without affecting food intake or lean mass.
• Insulin Sensitivity: BAM15 improves insulin sensitivity in multiple tissues, enhancing glucose uptake and utilization.
• Liver Health: It reduces liver fat accumulation and oxidative stress, contributing to overall metabolic health.
2. Cancer Therapy
• Tumor Growth Inhibition: BAM15 has demonstrated the ability to inhibit cell proliferation and promote apoptosis in non-small cell lung cancer (NSCLC) cells, suggesting its potential as an anticancer agent.
• Selective Targeting: Its selective action on mitochondrial uncoupling in tumor cells may offer a therapeutic advantage over traditional chemotherapeutic agents.
3. Acute Kidney Injury
• Renal Protection: BAM15 has been shown to protect against acute renal ischemic-reperfusion injury in mice, reducing kidney damage and improving survival rates.
4. Cardiovascular Health
• Vascular Smooth Muscle Relaxation: BAM15 has been found to relax constricted arteries and activate AMPK in vascular smooth muscle cells, indicating potential benefits for cardiovascular health.
5. Anti-Inflammatory Effects
• Inflammation Reduction: BAM15 has demonstrated anti-inflammatory effects, which could be beneficial in conditions associated with chronic inflammation.
⸻
Safety Profile and Limitations
• Tolerability: In preclinical studies, BAM15 has been well-tolerated with no significant adverse effects observed at therapeutic doses.
• Half-Life: The compound has a relatively short half-life of approximately 1.7 hours, which may necessitate frequent dosing or formulation improvements for sustained efficacy.
• Solubility: Its low aqueous solubility, while beneficial for mitochondrial penetration, may pose challenges for formulation and delivery.
⸻
Future Directions
Ongoing research aims to:
• Formulation Development: Enhance the bioavailability and half-life of BAM15 through novel drug delivery systems.
• Clinical Trials: Conduct human clinical trials to confirm efficacy and safety in treating obesity, metabolic disorders, and cancer.
• Combination Therapies: Explore the synergistic effects of BAM15 with other therapeutic agents to improve treatment outcomes.
⸻
Conclusion
BAM15 represents a promising therapeutic agent with the potential to address several metabolic and oncological conditions. Its unique mechanism of action and favorable safety profile make it a candidate for further clinical development.
Interested in BAM 15? It’s available right here: https://peptides.co.za/product/bam15-capsules/
BAM15 (N^5,N^6-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine) is a novel mitochondrial protonophore uncoupler that has emerged as a promising therapeutic agent. Unlike traditional uncouplers, BAM15 offers a more targeted approach with reduced side effects, making it a subject of extensive research.
⸻
Chemical Structure and Properties
• Molecular Formula: C₁₆H₁₀F₂N₆O
• CAS Number: 210302-17-3
• Solubility: Low aqueous solubility, which aids in its ability to penetrate cell membranes and mitochondria.
⸻
Mechanism of Action
BAM15 functions by uncoupling oxidative phosphorylation in mitochondria. This process involves:
• Protonophore Activity: BAM15 facilitates the transport of protons across the mitochondrial membrane, disrupting the proton gradient.
• Increased Oxygen Consumption: This disruption leads to an increase in oxygen consumption without a corresponding increase in ATP production, resulting in the dissipation of energy as heat.
• Activation of AMPK: The energy imbalance activates AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis.
⸻
Therapeutic Potential
1. Obesity and Metabolic Disorders
• Weight Management: Studies in mice have shown that BAM15 can prevent and reverse diet-induced obesity without affecting food intake or lean mass.
• Insulin Sensitivity: BAM15 improves insulin sensitivity in multiple tissues, enhancing glucose uptake and utilization.
• Liver Health: It reduces liver fat accumulation and oxidative stress, contributing to overall metabolic health.
2. Cancer Therapy
• Tumor Growth Inhibition: BAM15 has demonstrated the ability to inhibit cell proliferation and promote apoptosis in non-small cell lung cancer (NSCLC) cells, suggesting its potential as an anticancer agent.
• Selective Targeting: Its selective action on mitochondrial uncoupling in tumor cells may offer a therapeutic advantage over traditional chemotherapeutic agents.
3. Acute Kidney Injury
• Renal Protection: BAM15 has been shown to protect against acute renal ischemic-reperfusion injury in mice, reducing kidney damage and improving survival rates.
4. Cardiovascular Health
• Vascular Smooth Muscle Relaxation: BAM15 has been found to relax constricted arteries and activate AMPK in vascular smooth muscle cells, indicating potential benefits for cardiovascular health.
5. Anti-Inflammatory Effects
• Inflammation Reduction: BAM15 has demonstrated anti-inflammatory effects, which could be beneficial in conditions associated with chronic inflammation.
⸻
Safety Profile and Limitations
• Tolerability: In preclinical studies, BAM15 has been well-tolerated with no significant adverse effects observed at therapeutic doses.
• Half-Life: The compound has a relatively short half-life of approximately 1.7 hours, which may necessitate frequent dosing or formulation improvements for sustained efficacy.
• Solubility: Its low aqueous solubility, while beneficial for mitochondrial penetration, may pose challenges for formulation and delivery.
⸻
Future Directions
Ongoing research aims to:
• Formulation Development: Enhance the bioavailability and half-life of BAM15 through novel drug delivery systems.
• Clinical Trials: Conduct human clinical trials to confirm efficacy and safety in treating obesity, metabolic disorders, and cancer.
• Combination Therapies: Explore the synergistic effects of BAM15 with other therapeutic agents to improve treatment outcomes.
⸻
Conclusion
BAM15 represents a promising therapeutic agent with the potential to address several metabolic and oncological conditions. Its unique mechanism of action and favorable safety profile make it a candidate for further clinical development.
Interested in BAM 15? It’s available right here: https://peptides.co.za/product/bam15-capsules/